Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q2 2017 · 10-Q
Revenue$2.27B$2.27B−8.8% vs Q2 2016 Net Income$20.14M$20.14M−27.3% vs Q2 2016 EPS Diluted$0.33$0.33−26.7% vs Q2 2016 Gross Profit$273,533,000−8.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Operating Cash Flowderived-$56,136,000N/M Free Cash Flowderived-$62,423,000N/M Margins · derivedGross margin12.1%+0.0 pt vs Q2 2016
Operating margin1.4%−0.6 pt vs Q2 2016
Net margin0.9%−0.2 pt vs Q2 2016
ended Jun 30, 2017 · filed Aug 2, 2017 · 33 d after period end